Using Pharmacokinetic- Pharmacodynamic Relationships to Predict the Effect of Poor Compliance
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 41 (1) , 1-6
- https://doi.org/10.2165/00003088-200241010-00001
Abstract
Since it is difficult to improve patient compliance to drug prescriptions, an alternative is to select a drug with less consequences for poor compliance, that is, a drug that has the capacity of ‘forgiveness’. Forgiveness is the property of a drug which, when compared with another medicine with different pharmacokinetics and/or concentration-effect relationships, blunts the consequences of missing one or two doses in a row, or has a greater variability in the timing of intake. Simulations show that drugs with a concentration-effect relationship modelled with an effect compartment, for example a delayed response, have more forgiveness. A marker of forgiveness would be of some help for doctors deciding which drug to prescribe to patients who are poor compilers.Keywords
This publication has 8 references indexed in Scilit:
- Revisiting the effect compartment through timing errors in drug administration.Trends in Pharmacological Sciences, 1998
- Role of Patient Compliance in Clinical PharmacokineticsClinical Pharmacokinetics, 1994
- A pharmacokinetic perspective on medicament noncomplianceClinical Pharmacology & Therapeutics, 1993
- Surrogate endpoints: A basis for a rational approachEuropean Journal of Clinical Pharmacology, 1992
- RELATIONSHIP BETWEEN PLASMA MEXILETINE LEVELS AT STEADY‐STATE: PRESENCE OF VENTRICULAR ARRHYTHMIAS AND SIDE EFFECTSFundamental & Clinical Pharmacology, 1987
- Kinetics of pharmacologic responsePharmacology & Therapeutics, 1982
- Kinetics of interaction between drugs and biological systems.1968